Press Releases

African Americans Against Alzheimer’s Leads Sustained Effort to Increase Minority Participation in Clinical Trials

September 22, 2014

Washington, DC – African Americans are two to three times more likely to develop Alzheimer’s disease than white Americans, yet they are less likely to be diagnosed. While Alzheimer’s is the sixth leading cause of death in the United States, it is the fourth leading cause of death for older African Americans. Alzheimer’s is the only disease in the top ten that currently has no cure, treatment, or prevention.

Statement by George Vradenburg on World Alzheimer’s Day

September 19, 2014

Washington, DC – George Vradenburg, founder of USAgainstAlzheimer’s and convener of the Global CEO Initiative on Alzheimer’s Disease, released the following statement in recognition of World Alzheimer’s Day. Vradenburg is also a member of the Advisory Council on Research, Care and Services to the U.S.

ClergyAgainstAlzheimer’s Urges Religious Leaders to Mark World Alzheimer’s Day in their Congregations

September 15, 2014

Washington, DC – The ClergyAgainstAlzheimer’s Network, a diverse, multi-faith, national network of clergy working to focus our nation’s attention on Alzheimer’s disease, is calling on religious leaders and clergy to mark World Alzheimer’s Day in their congregations’ sermons and addresses during the weekend of September 19-21.

WomenAgainstAlzheimer’s Launches Shadow Box Memory Project at Women’s Summit

September 11, 2014

Washington, DC – WomenAgainstAlzheimer’s, a robust and growing national network of influential women focused on ending Alzheimer’s, will hold its second annual Women’s Summit in Washington, DC on September 16-17. In addition to briefings from leading Alzheimer’s experts, the Out of the Shadows Summit will launch the Shadow Box Memory Project.

Meryl Comer Joins Diane Rehm to Discuss New Book and Caregiving

August 25, 2014

Meryl Comer: "Slow Dancing With A Stranger: Lost And Found In The Age Of Alzheimer's"

Why 2020?

USAgainstAlzheimer’s has retained its goal of stopping Alzheimer’s by 2020 rather than endorsing the goal of the National Plan to Address Alzheimer’s Disease that calls for preventing and effectively treating the disease by 2025. While we support the national plan and its goals, we believe, as most every family touched by Alzheimer’s disease believes, that preventing and effectively treating Alzheimer's by 2025 is simply too long a wait for concrete progress. There are promising avenues of drug discovery and development that will, if successful, deliver a means of slowing or deferring Alzheimer's symptoms by 2020. By voicing the urgency felt by so many families, we will pressure researchers and industry to do all in their power to make that happen.